Hangzhou Weicheng Network Technology Co., LTD – Trademark Portfolio

Entity Type: 16

Hangzhou Weicheng Network Technology Co., LTD holds 4 U.S. trademarks filed with the United States Patent and Trademark Office (USPTO), with a strong focus on Class 25 (Clothing) — 4 filings in this category. Currently, 3 trademarks are registered. Notable registered marks include FTIMILD, ZIOLOMA, and WEEN CHARM. The owner is based in Flushing, NY.

135-53 Northern Blvd, Apt 5B

135-53 Northern Blvd, Apt 5B

Flushing, NY 11354

4 Total Trademarks

Add to watchlist:

No watchlists yet
Loading...
By Date
By Name
Filter by Class:

FTIMILD
FTIMILD
Registered 2019
ZIOLOMA
ZIOLOMA
Registered 2018

Trademark Classifications

Hangzhou Weicheng Network Technology Co., LTD's trademark portfolio spans 1 Nice Classification class, reflecting the scope of goods and services protected under their brand portfolio.

25
Clothing (4 filings)

Clothing, footwear, headgear

Frequently Asked Questions

How many trademarks does Hangzhou Weicheng Network Technology Co., LTD have?

Hangzhou Weicheng Network Technology Co., LTD has 4 U.S. trademarks filed with the USPTO. Of these, 3 registered, 1 abandoned.

What trademark classes does Hangzhou Weicheng Network Technology Co., LTD file in?

Hangzhou Weicheng Network Technology Co., LTD files trademarks across 1 Nice Classification class. The most active classes are Class 25 (Clothing). Class 25 covers clothing, footwear, headgear.

What are Hangzhou Weicheng Network Technology Co., LTD's most well-known trademarks?

Hangzhou Weicheng Network Technology Co., LTD's registered trademark portfolio includes well-known marks such as FTIMILD, ZIOLOMA, and WEEN CHARM. These are among 3 currently registered trademarks in the portfolio.

What is Hangzhou Weicheng Network Technology Co., LTD's trademark registration success rate?

Hangzhou Weicheng Network Technology Co., LTD has a 75% trademark registration rate, with 3 out of 4 resolved applications resulting in successful registration. Currently, 0 applications are pending review.